Full Year 2023 SanBio Co Ltd Earnings Call Transcript
Good afternoon. This is Keita Mori from SanBio, and we are delighted to provide updates today. So thanks for gathering. As usual, we've got 3 topics today: financial results, SB623 in Japan and then everything else.
Before I start talking about the actual topics, I would like to touch a little bit on the new executive leadership. Many of you may have heard about the resignation of (inaudible) back in January. So this is sort of a response to where we stand as of today and show our leadership. As you can see, we have a very strong leadership. We have expanded our leadership in the last year or 2, quite tremendously. And we have professionals and leaders with tons of experience in pharma and biotech.
In addition, 2 founders, myself and Toru Kawanishi have been on this SanBio since the beginning in 2001. So this is our 23rd year ongoing. So this is a new executive leadership, and we believe we have a more than hour to go through the approval process, our first product approval
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |